Showing Results for
- Academic Journals (10)
Search Results
- 10
Academic Journals
- 10
- Search Terms:
- 1From: Cancer Gene Therapy. (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Andrea L Volk [1, 2]; Angel A Rivera [1]; Grier P Page [3]; Jesus F Salazar-Gonzalez [4]; Dirk M Nettelbeck [1, 5]; Qiana L Matthews [1]; David T Curiel [1] Human adenovirus C vectors are attractive as gene...
- 2From: Cancer Gene Therapy. (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Geng-Feng Fu [1, 2, 3]; Xi Li [4]; Ya-Yi Hou [1]; Yan-Rong Fan [2, 3]; Wen-Hua Liu [2, 3]; Gen-Xing Xu [1, 2, 3] Uncontrolled tumor growth is one of the leading causes of death. Tumor progression and...
- 3From: Cancer Gene Therapy. (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Milcho Mincheff [1, 4]; Serguei Zoubak [1]; Iskra Altankova [2]; Stoyan Tchakarov [3]; Petro Pogribnyy [1]; Yevgen Makogonenko [1]; Chavdar Botev [4]; Harold T Meryman [1] In a previous study,[1] we found...
- 4From: Cancer Gene Therapy. (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Dietmar Jacob [1]; John J Davis [1, 2]; Lidong Zhang [1]; Hongbo Zhu [1]; Fuminori Teraishi [1]; Bingliang Fang [1, 2] Pancreatic cancer is the fourth leading cause of cancer-related death in the United...
- 5From: Cancer Gene Therapy. (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Yongqing Liu [1]; Dajing Xia [1]; Fang Li [1]; Changyu Zheng [2]; Jim Xiang [1] Dendritic cells (DCs) are the most potent antigen-presenting cells (APC) for the initiation of antigen (Ag)-specific immune...
- 6From: Cancer Gene Therapy. (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Bastien Calmels [1]; Stéphane Paul [1]; Nicolas Futin [2]; Catherine Ledoux [3]; Fabienne Stoeckel [4]; Bruce Acres [5] Manipulation of the immune response depends upon the knowledge of the numerous...
- 7From: Cancer Gene Therapy. (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Byeong-Ho Park [1]; Jin-Hwa Lee [1]; Jin-Sook Jeong [2]; Seo-Hee Rha [2]; Seung-Eun Kim [3]; Jae-Seok Kim [3, 4]; Jeong-Man Kim [5]; Tae-Ho Hwang [4, 6] Adenoviral vectors are particularly important...
- 8From: Cancer Gene Therapy. (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Che-Hsin Lee [1]; Chao-Liang Wu [1, 2]; Ai-Li Shiau [1, 3] The use of preferentially replicating bacteria as an oncolytic agent is one of the innovative approaches for the treatment of cancer. This is based...
- 9From: Cancer Gene Therapy. (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Hitoshi Fujiwara [1]; Takeshi Kubota [1]; Hisashi Amaike [1]; Satoshi Inada [1]; Kazuhiro Takashima [1]; Kiyoto Atsuji [1]; Mamoru Yoshimura [1]; Makoto Maemondo [2]; Ko Narumi [2]; Toshihiro Nukiwa [2]; Kunio...
- 10From: Cancer Gene Therapy. (Vol. 12, Issue 2) Peer-ReviewedAuthor(s): Bart Everts [1]; Henk G van der Poel [2] Cancer has become one of the leading causes of death in the Western society. As current cancer therapies, like radiotherapy and chemotherapy, have often only a...